Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M50,149Revenue $M19,939Net Margin (%)8.9Altman Z-Score2.2
Enterprise Value $M61,046EPS $2.1Operating Margin %21.9Piotroski F-Score4
P/E(ttm)28.5Beneish M-Score-2.7Pre-tax Margin (%)11.9Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %14.6Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %4.7Current Ratio1.0Lower Leverage y-yN
Price/Free Cash Flow14.5y-y EBITDA Growth Rate %6.4ROA % (ttm)3.7Higher Current Ratio y-yN
Dividend Yield %2.3PEG6.3ROE % (ttm)7.7Less Shares Outstanding y-yN
Payout Ratio %65.0Shares Outstanding M852ROIC % (ttm)8.3Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAVanguard Health Care Fund 2015-12-31 Buy 0.76%$55.96 - $66.32
($61.94)
$ 58.86-5%New holding5,800,000
TEVAJames Barrow 2015-12-31 Add0.01%$55.96 - $66.32
($61.94)
$ 58.86-5%Add 0.84%9,602,463
TEVAJohn Paulson 2015-09-30 Add4.82%$55.08 - $72
($64.84)
$ 58.86-9%Add 786.48%18,000,000
TEVANWQ Managers 2015-09-30 Reduce-0.46%$55.08 - $72
($64.84)
$ 58.86-9%Reduce -19.29%2,408,826
TEVAGeorge Soros 2015-09-30 Sold Out -0.26%$55.08 - $72
($64.84)
$ 58.86-9%Sold Out0
TEVADavid Dreman 2015-09-30 Reduce-0.23%$55.08 - $72
($64.84)
$ 58.86-9%Reduce -52.52%42,892
TEVAFirst Eagle Investment 2015-09-30 Add0.1%$55.08 - $72
($64.84)
$ 58.86-9%Add 18.90%4,467,011
TEVAJames Barrow 2015-09-30 Reduce-0.03%$55.08 - $72
($64.84)
$ 58.86-9%Reduce -3.45%9,522,401
TEVAJohn Keeley 2015-09-30 Reduce$55.08 - $72
($64.84)
$ 58.86-9%Reduce -0.80%35,990
TEVARonald Muhlenkamp 2015-09-30 Add$55.08 - $72
($64.84)
$ 58.86-9%Add 0.02%176,955
TEVAJohn Paulson 2015-06-30 Buy 0.57%$58.91 - $67.14
($61.7)
$ 58.86-5%New holding2,030,500
TEVANWQ Managers 2015-06-30 Reduce-0.53%$58.91 - $67.14
($61.7)
$ 58.86-5%Reduce -18.66%2,984,606
TEVAGeorge Soros 2015-06-30 Buy 0.26%$58.91 - $67.14
($61.7)
$ 58.86-5%New holding423,308
TEVAVanguard Health Care Fund 2015-06-30 Sold Out -0.25%$58.91 - $67.14
($61.7)
$ 58.86-5%Sold Out0
TEVAFirst Eagle Investment 2015-06-30 Reduce-0.07%$58.91 - $67.14
($61.7)
$ 58.86-5%Reduce -10.66%3,756,998
TEVADavid Dreman 2015-06-30 Reduce-0.05%$58.91 - $67.14
($61.7)
$ 58.86-5%Reduce -9.77%90,345
TEVAJames Barrow 2015-06-30 Reduce-0.03%$58.91 - $67.14
($61.7)
$ 58.86-5%Reduce -3.21%9,862,843
TEVAJohn Keeley 2015-06-30 Reduce$58.91 - $67.14
($61.7)
$ 58.86-5%Reduce -1.51%36,280
TEVARonald Muhlenkamp 2015-06-30 Add$58.91 - $67.14
($61.7)
$ 58.86-5%Add 0.12%176,915
TEVACharles Brandes 2015-06-30 Sold Out $58.91 - $67.14
($61.7)
$ 58.86-5%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    NWQ Managers Reduces Stakes in Microsoft, MetLife and Teva Pharmaceutical Dec 23 2015 
    Halvorsen's Investment Makes Broadcom His Fifth-Most Valuable Stake Dec 05 2015 
    John Paulson Increases Holding in Teva Pharmaceutical Nov 17 2015 
    KEELEY All Cap Value Fund Q3 2015 Manager Commentary Nov 03 2015 
    Hedge Fund Menta Capital's Top Stocks Include Teva Pharmaceutical, NICE Systems Sep 09 2015 
    Daniel Loeb's Third Point Second Quarter Investor Letter Aug 03 2015 
    Weekly 52-Week Highs Highlight: GIS, AAP, BCR, TEVA Jul 28 2015 
    Paul Tudor Jones Buys Stakes in ADP and Visa Jun 19 2015 
    KEELEY All Cap Value Fund First Quarter 2015 Commentary Jun 17 2015 
    Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks Jun 11 2015 

    More From Other Websites
    Factors of Influence in Today's Market - Analyst Notes on Hess, Teva Pharmaceutical Industries,... Feb 05 2016
    The 4 'Momentum Triggers' That Could Give This Biotech Stock 64% Growth Feb 02 2016
    Teva Shareholders Shrug Off Latest Collaborative Research Agreement Feb 02 2016
    Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies Feb 02 2016
    Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies Feb 02 2016
    U.S. appeals court ruling may clear barrier to generic OxyContin Feb 01 2016
    How Much Is Teva Spending on Research and Development? Jan 29 2016
    Antitrust Watchdog: Usual Merger Fix Won't Help Teva's Allergan Deal Jan 29 2016
    Insight into Teva’s Over-the-Counter and Distribution Businesses Jan 28 2016
    Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine... Jan 28 2016
    Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine... Jan 28 2016
    Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine... Jan 28 2016
    Short Sellers Become More Selective on Major Pharma Jan 28 2016
    Teva to Report Fourth Quarter 2015 Financial Results on February 11, 2016 Jan 28 2016
    Teva to Report Fourth Quarter 2015 Financial Results on February 11, 2016 Jan 28 2016
    Teva Releases Innovation and Social Responsibility Highlights Jan 25 2016
    Teva Releases Innovation and Social Responsibility Highlights Jan 25 2016
    How Will Teva Finance the Actavis Acquisition? Jan 21 2016
    Teva’s Debt Position and Valuations Jan 19 2016
    United Therapeutics settles patent dispute with Teva Pharmaceuticals Jan 19 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK